Pedro has been appointed as part of ISCT’s Early-Stage Leadership Development Program, this appointment reflects his expertise in gene therapy biomanufacturing, non-viral gene delivery, and nanoparticle-based therapeutics. In this role, he will contribute to the journal’s mission of advancing research in the field.